PREDICTION OF MORTALITY IN SSC-ILD DEPENDS ON DEFINITION OF ILD PROGRESSION

被引：0
作者：
Hoffmann-Vold, A. M. [1 ,2 ]
Petelytska, L. [2 ]
Fretheim, H. [1 ]
Barua, I. [1 ]
Becker, M. O.
Bjorkekjaer, H. J. [3 ]
Brunborg, C. [4 ]
Bruni, C. [2 ]
Diep, P. P.
Dobrota, R. [2 ]
Durheim, M. [5 ]
Elhai, M. [2 ]
Jordan, S. [2 ]
Langballe, E. [1 ]
Midtvedt, O. [1 ]
Mihai, C. [2 ]
Molberg, O. [1 ]
Distler, O. [2 ]
机构：
[1] Oslo Univ Hosp, Rheumatol, Oslo, Norway
[2] Univ Zurich, Univ Hosp Zurich, Rheumatol, Zurich, Switzerland
[3] Hosp Southern Norway, Rheumatol, Kristiansand, Norway
[4] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Oslo, Norway
[5] Oslo Univ Hosp, Resp Med, Oslo, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Lungs; Systemic sclerosis; Prognostic factors;
D O I：
10.1136/annrheumdis-2023-eular.3181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1291
引用
收藏
页码：992 / 993
页数：2
相关论文
共 44 条
  • [31] Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders
    Iudici, Michele
    Cuomo, Giovanna
    Vettori, Serena
    Bocchino, Marialuisa
    Zamparelli, Alessandro Sanduzzi
    Cappabianca, Salvatore
    Valentini, Gabriele
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (04) : 437 - 444
  • [32] Worsening of esophageal dilatation is associated with increase in a high-resolution computed tomography (HRCT) score in early systemic sclerosis-associated interstitial lung disease(SSc-ILD)
    Wangkaew, Suparaporn
    Losuriya, Phumiphat
    Euathrongchit, Juntima
    CLINICAL RHEUMATOLOGY, 2021, 40 (03) : 955 - 963
  • [33] Worsening of esophageal dilatation is associated with increase in a high-resolution computed tomography (HRCT) score in early systemic sclerosis-associated interstitial lung disease (SSc-ILD)
    Suparaporn Wangkaew
    Phumiphat Losuriya
    Juntima Euathrongchit
    Clinical Rheumatology, 2021, 40 : 955 - 963
  • [34] COMPARISON OF THE EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE (SP) AND RITUXIMAB (RTM) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 373A - 373A
  • [35] COMPARISON OF THE RITUXIMAB (RTM) EFFICACY IN MONOTHERAPY REGIMEN AND IN COMBINATION WITH IMMUNOSUPPRESSANTS IN SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 374A - 374A
  • [36] ORGAN INVOLVEMENT AND ILD PROGRESSION IN SCLERODERMA PATIENTS WITH ANTI-TOPOISOMERASE I SPECIFICITY AND LIMITED CUTANEOUS FORM
    Zanatta, E.
    Polito, P.
    Ometto, F.
    Felicetti, M.
    Tonello, M.
    Scanu, A.
    Punzi, L.
    Cozzi, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1101 - 1101
  • [37] Hypouricemia as a novel predictor of mortality in anti-MDA5 positive dermatomyositis patients with ILD: A retrospective cohort study
    Liu, Hongjiang
    Chen, Bo
    Guo, Yixue
    Liu, Huan
    Ran, Jingjing
    Liu, Ruiting
    Yin, Geng
    Xie, Qibing
    RESPIRATORY MEDICINE, 2024, 222
  • [38] Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)
    Rojas-Serrano, Jorge
    Herrera-Bringas, Denisse
    Mejia, Mayra
    Rivero, Hermes
    Mateos-Toledo, Heidegger
    Figueroa, Jose E.
    CLINICAL RHEUMATOLOGY, 2015, 34 (09) : 1563 - 1569
  • [39] PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD
    Alp, Gizem Tugce
    Vasi, Ibrahim
    Alp, Emre
    Guler, Aslihan Avanoglu
    Karadeniz, Hazan
    Gulbahar, Ozlem
    Erden, Abdulsamet
    Tufan, Abdurrahman
    Ozturk, Mehmet Akif
    Goker, Berna
    Haznedaroglu, Seminur
    Kucuk, Hamit
    BIOMARKERS IN MEDICINE, 2025, : 349 - 355
  • [40] COMPARISON OF FOUR RISK STRATIFICATION MODELS FOR PREDICTION OF MORTALITY IN SSc-PAH IN THE EUSTAR COHORT
    Bjorkekjaer, H. J.
    Bruni, C.
    Carreira, P.
    Airo, P.
    Aznar, C. P. Simeon
    Truchetet, M. E.
    Giollo, A.
    Balbir-Gurman, A.
    Martin, M.
    Denton, C. P.
    Gabrielli, A.
    Fretheim, H.
    Barua, I.
    Bitter, H.
    Midtvedt, O.
    Garen, T.
    Broch, K.
    Andreassen, A.
    Tanaka, Y.
    Riemekasten, G.
    Mueller-Ladner, U.
    Matucci-Cerinic, M.
    Castellvi, I.
    Siegert, E.
    Hachulla, E.
    Distler, O.
    Hoffmann-Vold, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 277 - 278
12345